Initially discovered on hematopoietic cells, HHLA2 has subsequently been shown to be aberrantly upregulated in various solid tumors, including HCC, highlighting its potential role in oncogenesis. This evidence concerns the gene HHLA2 and hepatocellular carcinoma.